The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria.

作者: M Ploug , T Plesner , E Ronne , V Ellis , G Hoyer-Hansen

DOI: 10.1182/BLOOD.V79.6.1447.1447

关键词:

摘要: Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal defect in bone marrow-derived cells and clinically associated with intravascular hemolysis, hemoglobinuria, increased frequency of venous thrombosis. The common denominator PNH-affected blood appears to be a the membrane attachment proteins normally anchored by glycosyl-phosphatidylinositol (GPI). We report here that cellular receptor for urokinase-type plasminogen activator (u-PAR) deficient on affected peripheral monocytes granulocytes from four individuals PNH as evidenced chemical cross-linking analysis well immunofluorescence flow cytometry using monoclonal anti-u-PAR antibody. In contrast, normal we find significant amounts u-PAR, which attached plasma GPI-anchor defined its sensitivity towards specific phospholipase treatment. By two-color it was shown deficiency u-PAR expression paralleled another GPI-anchored protein. As involved initiation pericellular proteolysis, reduced leukocytes led overall reduction capacity activation cell-surface-bound urokinase. Whereas abnormal susceptibility erythrocytes lysis autologous complement has been related low three regulatory cell surface, now propose lack surface may causally high incidence thrombosis observed patients.

参考文章(53)
K. Danø, P.A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L.S. Nielsen, L. Skriver, Plasminogen activators, tissue degradation, and cancer. Advances in Cancer Research. ,vol. 44, pp. 139- 266 ,(1985) , 10.1016/S0065-230X(08)60028-7
Danø K, Bach F, Nielsen Ls, Grøndahl-Hansen J, Agerlin N, Munkholm-Larsen P, Dombernowsky P, Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer. Journal of Laboratory and Clinical Medicine. ,vol. 111, pp. 42- 51 ,(1988)
M.P. Lisanti, M.C. Field, I.W. Caras, A.K. Menon, E. Rodriguez-Boulan, Mannosamine, a novel inhibitor of glycosylphosphatidylinositol incorporation into proteins. The EMBO Journal. ,vol. 10, pp. 1969- 1977 ,(1991) , 10.1002/J.1460-2075.1991.TB07726.X
JE Murphy-Ullrich, DF Mosher, Localization of thrombospondin in clots formed in situ. Blood. ,vol. 66, pp. 1098- 1104 ,(1985) , 10.1182/BLOOD.V66.5.1098.1098
N Behrendt, E Rønne, M Ploug, T Petri, D Løber, L S Nielsen, W D Schleuning, F Blasi, E Appella, K Danø, The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. Journal of Biological Chemistry. ,vol. 265, pp. 6453- 6460 ,(1990) , 10.1016/S0021-9258(19)39348-2
V Ellis, T C Wun, N Behrendt, E Rønne, K Danø, Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. Journal of Biological Chemistry. ,vol. 265, pp. 9904- 9908 ,(1990) , 10.1016/S0021-9258(19)38757-5
B Rotoli, R Robledo, N Scarpato, L Luzzatto, Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria. Blood. ,vol. 64, pp. 847- 851 ,(1984) , 10.1182/BLOOD.V64.4.847.847
V Ellis, M F Scully, V V Kakkar, Plasminogen Activation Initiated by Single-chain Urokinase-type Plasminogen Activator Journal of Biological Chemistry. ,vol. 264, pp. 2185- 2188 ,(1989) , 10.1016/S0021-9258(18)94159-1